BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2543581)

  • 1. Modifications induced by diabetes on the physicochemical and functional properties of erythrocyte plasma membrane.
    Mazzanti L; Rabini RA; Testa I; Bertoli E
    Eur J Clin Invest; 1989 Feb; 19(1):84-9. PubMed ID: 2543581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Na+/K(+)-ATPase activity and fluidity of erythrocyte membranes from relatives of insulin dependent diabetic patients.
    Rabini RA; Galassi R; Staffolani R; Vasta M; Fumelli P; Mazzanti L
    Diabetes Res; 1993; 22(1):33-40. PubMed ID: 8200183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal membrane fluidity and acetylcholinesterase activity in erythrocytes from insulin-dependent diabetic patients.
    Testa I; Rabini RA; Fumelli P; Bertoli E; Mazzanti L
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1129-33. PubMed ID: 2848052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma.
    Finotti P; Palatini P
    Diabetologia; 1986 Sep; 29(9):623-8. PubMed ID: 3025045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
    Mimura M; Makino H; Kanatsuka A; Yoshida S
    Metabolism; 1992 Apr; 41(4):426-30. PubMed ID: 1313528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid, diabetes, and aging: a study on the erythrocyte membrane.
    Mazzanti L; Rabini RA; Salvolini E; Tesei M; Martarelli D; Venerando B; Curatola G
    Metabolism; 1997 Jan; 46(1):59-61. PubMed ID: 9005970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.
    De La Tour DD; Raccah D; Jannot MF; Coste T; Rougerie C; Vague P
    Diabetologia; 1998 Sep; 41(9):1080-4. PubMed ID: 9754827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrocyte membrane abnormality of essential hypertension with special reference to membrane fluidity and Na(+)-K+ ATPase activity].
    Sakamoto K
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):562-75. PubMed ID: 1663477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic acid content in erythrocyte membranes from pregnant women affected by gestational diabetes.
    Moretti N; Rabini RA; Nanetti L; Grechi G; Curzi MC; Cester N; Tranquilli LA; Mazzanti L
    Metabolism; 2002 May; 51(5):605-8. PubMed ID: 11979393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process.
    Mazzanti L; Faloia E; Rabini RA; Staffolani R; Kantar A; Fiorini R; Swoboda B; De Pirro R; Bertoli E
    Clin Biochem; 1992 Feb; 25(1):41-6. PubMed ID: 1312917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension.
    Rodrigo R; Miranda-Merchak A; Valenzuela Grau R; Bachler JP; Vergara L
    Clin Exp Hypertens; 2014; 36(1):17-26. PubMed ID: 23659494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients.
    Rabini RA; Galassi R; Fumelli P; Dousset N; Solera ML; Valdiguie P; Curatola G; Ferretti G; Taus M; Mazzanti L
    Diabetes; 1994 Jul; 43(7):915-9. PubMed ID: 8013757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients.
    Raccah D; Fabreguetts C; Azulay JP; Vague P
    Diabetes Care; 1996 Jun; 19(6):564-8. PubMed ID: 8725852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Na,K-adenosine triphosphatase (ATPase) concentration and Na,K-ATPase-dependent adenosine triphosphate turnover in human erythrocytes in diabetes.
    Garner MH
    Metabolism; 1996 Aug; 45(8):927-34. PubMed ID: 8769346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D; Gallice P; Pouget J; Vague P
    Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Na(+)-K+ ATPase activity in uraemic adolescents.
    Vásárhelyi B; Sallay P; Balog E; Reusz G; Tulassay T
    Acta Paediatr; 1996 Aug; 85(8):919-22. PubMed ID: 8863871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifications induced by gestational diabetes mellitus on cellular membrane properties.
    Mazzanti L; Staffolani R; Rabini RA; Romanini C; Cugini AM; Benedetti G; Cester N; Faloia E; De Pirro R
    Scand J Clin Lab Invest; 1991 Sep; 51(5):405-10. PubMed ID: 1658918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and functional modifications induced by obesity on human erythrocyte membranes.
    Faloia E; Garrapa GG; Martarelli D; Camilloni MA; Lucarelli G; Staffolani R; Mantero F; Curatola G; Mazzanti L
    Eur J Clin Invest; 1999 May; 29(5):432-7. PubMed ID: 10354200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal erythrocyte Na, K-ATPase activity in a northeastern Thai population.
    Tosukhowong P; Chotikasatit C; Tungsanga K; Sriboonlue P; Prasongwattana V; Pansin P; Sitprija V
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):526-30. PubMed ID: 1336901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K(+)-permeability in diabetics and nondiabetics with and without renal insufficiency.
    Kraatz G; Wolf E; Gruska S
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():19-21. PubMed ID: 9288537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.